| Literature DB >> 32752913 |
Qun Lu1,2, Yuan Lin3, Ting Chen4, Hong Lv1,2, Feiyang Diao5, Cong Liu1,2, Meijuan Peng1,2, Xiufeng Ling6, Hong Li7, Yun Wang8, Yongyue Wei2,9, Jiangbo Du1,2, Guangfu Jin1,2, Yankai Xia1,2, Hongxia Ma1,2, Xingyin Liu1, Hongbing Shen1,2, Zhibin Hu1,2.
Abstract
The gut microbiome in newborns may be strongly influenced by their intrinsic host microenvironmental factors (e.g., the gestational age) and has been linked to their short-term growth and potentially future health. It is yet unclear whether early microbiota composition is significantly different in newborns conceived by assisted reproductive technology (ART) when compared with those who were conceived spontaneously. Additionally, little is known about the effect of gut microbiota composition on weight gain in early infancy. We aimed to characterize the features and the determinants of the gut microbiome in ART newborns and to assess the impact of early microbiota composition on their weight gain in early infancy in mother-infant dyads enrolled in the China National Birth Cohort (CNBC). Among 118 neonates born by ART and 91 neonates born following spontaneous conception, we observed significantly reduced gut microbiota α-diversity and declined Bacteroidetes relative abundance in ART neonates. The microbiota composition of ART neonates was largely driven by specific ART treatments, hinting the importance of fetus intrinsic host microenvironment on the early microbial colonization. Following up these neonates for six months after their births, we observed the effects of gut microbiome composition on infant rapid weight gaining. Collectively, we identified features and determinants of the gut microbiota composition in ART neonates, and provided evidence for the importance of microbiota composition in neonatal growth.Entities:
Keywords: Assisted reproductive technology (ART); Birth Cohort; bacteroidetes; meconium microbiome; weight gain
Year: 2020 PMID: 32752913 PMCID: PMC7524295 DOI: 10.1080/19490976.2020.1794466
Source DB: PubMed Journal: Gut Microbes ISSN: 1949-0976
Demographic and clinical characteristics of the participants.
| Characteristics | ART ( | Spontaneous ( | |
|---|---|---|---|
| Age (years) | 30.47 ± 3.70 | 29.76 ± 4.34 | 2.14 × 10−01 |
| Pre-pregnancy BMI (kg/m2) | 21.70 ± 2.91 | 21.74 ± 4.14 | 9.47 × 10−01 |
| Gravidity | 3.69 × 10−01 | ||
| 0 | 54(45.76) | 36(39.56) | |
| > 0 | 64(54.24) | 55(60.44) | |
| Mode of delivery | 5.06 × 10−10 | ||
| Cesarean section | 100(84.75) | 40(43.96) | |
| Vaginal | 18(15.25) | 51(56.04) | |
| Gender | 1.27 × 10−01 | ||
| Male | 67(56.78) | 42(46.15) | |
| Female | 51(43.22) | 49(53.85) | |
| Gestational age (weeks) | 38.28 ± 1.61 | 39.49 ± 0.90 | 7.30 × 10−10 |
| Birth weight (g) | 3225.85 ± 492.35 | 3255.28 ± 485.11 | 6.66 × 10−01 |
| Feeding mode | 9.53 × 10−02 | ||
| Exclusively breast-fed (%) | 51(43.22) | 51(56.04) | |
| Exclusively formula-fed (%) | 4(3.39) | 5(5.49) | |
| Mixed fed (formula + breast-feeding) (%) | 63(53.39) | 35(38.46) | |
| Regimen for ovulation induction | |||
| Antagonist regimen | 26(22.03) | ||
| Microstimulation | 10(8.47) | ||
| Agonist long regimen | 29(24.58) | ||
| Short-acting long regimen | 53(44.92) | ||
| HCG_E2 (ng/mL) | 3.96 ± 2.38 | ||
| HCG_P (ng/mL) | 0.94 ± 0.90 | ||
| HCG_Endometrial thickness (mm) | 10.35 ± 2.53 | ||
| Corpus luteum support drugs through the vagina | |||
| no | 27(22.88) | ||
| yes | 91(77.12) | ||
| Oral or injection of corpus luteum support drugs | |||
| no | 10(8.47) | ||
| yes | 108(91.53) | ||
| Insemination method | |||
| IVF | 75(63.56) | ||
| ICSI | 43(36.44) | ||
| Transplant embryo type | |||
| Fresh | 34(28.81) | ||
| Frozen | 84(71.19) |
N = 209 dyads from the CNBC cohort. Data are presented as mean ± SD or counts and percentages, respectively. Continuous variables were tested by Student’s t test. Nominal variables were tested either with χ2 test or Fisher’s exact test.
BMI, body mass index; HCG_E2, Estradiol level at HCG day; HCG_P, Progesterone level at HCG day; HCG_Endometrial thickness, Endometrial thickness at HCG day.
Figure 1.The first meconium microbiome exhibit discrete composition between ART and spontaneous conception groups.
The association of specific ART treatments with the microbiota composition in the ART-conceived neonates.
| ART treatments | Diversity (Simpson index)a | Bacteroidetes abundancea | ||
|---|---|---|---|---|
| β (95% CI) | β (95% CI) | |||
| Polycystic ovary syndrome | ||||
| No ( | Ref. | Ref. | ||
| Yes ( | 0.09 (−0.08,0.26) | 2.93 × 10−01 | −0.04 (−0.12,0.05) | 4.12 × 10−01 |
| Regimen for ovulation induction | ||||
| Agonist long regimen ( | Ref. | Ref. | ||
| Short-acting long regimen ( | −0.004 (−0.14,0.13) | 9.48 × 10−01 | −0.04 (−0.10,0.02) | 2.35 × 10−01 |
| Antagonist regimen ( | −0.01 (−0.17,-0.14) | 8.61 × 10−01 | −0.09 (−0.17,-0.02) | 1.90 × 10−02 |
| Microstimulation ( | 0.06 (−0.15,0.28) | 5.69 × 10−01 | −0.03 (−0.13,0.07) | 5.73 × 10−01 |
| Estradiol levels on the hCG day (ng/mL) ( | 0.01 (−0.01,0.03) | 3.33 × 10−01 | −0.01 (−0.02,-0.002) | 2.49 × 10−02 |
| Progesterone levels on the hCG day (ng/mL) ( | 0.002 (−0.07,0.07) | 9.49 × 10−01 | −0.02 (−0.05,0.02) | 3.59 × 10−01 |
| Endometrial thickness on the hCG day (mm) ( | −0.01 (−0.03,0.01) | 4.59 × 10−01 | 0.002 (−0.01,0.01) | 6.86 × 10−01 |
| Insemination method | ||||
| ICSI ( | Ref. | Ref. | ||
| IVF ( | −0.09 (−0.20,0.02) | 9.45 × 10−02 | −0.04 (−0.10,0.01) | 1.08 × 10−01 |
| Transplant embryo type | ||||
| Fresh ( | Ref. | Ref. | ||
| Frozen ( | 0.07 (−0.05,0.18) | 2.88 × 10−01 | −0.06 (−0.12,-0.01) | 2.89 × 10−02 |
| The usage of vaginal suppositories for luteal phase supportb | ||||
| no ( | Ref. | Ref. | ||
| yes ( | 0.09 (−0.04,0.22) | 1.63 × 10−01 | 0.11 (0.04,0.17) | 1.79 × 10−03 |
| Oral or injection of corpus luteum support drugsb | ||||
| no ( | Ref. | Ref. | ||
| yes ( | 0.14 (−0.07,0.36) | 1.94 × 10−01 | 0.04 (−0.06,0.15) | 4.11 × 10−01 |
aAdjusted for gestational age, mode of delivery, and infant gender.
bAdjusted for gestational age, mode of delivery, infant gender, and transplant embryo type.
Figure 2.Associations between vaginal luteal support and gut Bacteroidetes abundance in the neonates conceived by ART.
Figure 3.Determinants of neonates gut microbiota composition and the effects of microbiota composition on neonatal growth.
Association of infant gut microbiota composition with neonatal 42-day and 6-month weight gain rates.
| Birth weight(g)a | 42 days weight gain rate(g/d)b | 6 months weight gain rate(g/d)b | ||||
|---|---|---|---|---|---|---|
| β (95% CI) | β (95% CI) | β (95% CI) | ||||
| Diversity: Simpson | 138.93 (−159.99,437.86) | 3.64 × 10−01 | −10.98 (−18.33,-3.63) | 4.13 × 10−03 | −0.52 (−3.96,2.93) | 7.69 × 10−01 |
| Bacteroidetes abundance | 692.53 (−339.21,1724.28) | 1.91 × 10−01 | −56.35 (−80.67,-32.04) | 1.42 × 10−05 | −17.10 (−28.66,-5.54) | 4.54 × 10−03 |
| Diversity: Simpson | −241.72 (−635.71,152.28) | 2.33 × 10−01 | −7.18 (−17.47,3.12) | 1.75 × 10−01 | −3.38 (−7.76,1.01) | 1.35 × 10−01 |
| Bacteroidetes abundance | −58.05 (−718.95,602.85) | 8.64 × 10−01 | −39.22 (−54.20,-24.24) | 1.83 × 10−06 | −16.20 (−22.50,-9.90) | 2.89 × 10−06 |
aLinear regression adjusted for gestational age, maternal BMI, and infant gender.
bLinear regression adjusted for gestational age, infant gender, birth weight, and feeding method.